SCHEMBL19269582

SCHEMBL19269582

C=C/C(=C\C=C\OC)Nc1ccccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.45
▸ RAB9A P51151 8/20 0.45
▸ PKM P14618 3/20 0.45
▸ SMN1; SMN2 Q16637 5/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ KMT2A Q03164 4/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ GAA P10253 2/20 0.41
▸ TP53 P04637 2/20 0.41
▸ F2 P00734 1/20 0.41
▸ ALOX12 P18054 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ CHRNB2 P17787 1/20 0.40
▸ CHRNB4 P30926 1/20 0.40
▸ CHRNA3 P32297 1/20 0.40
▸ CHRNA4 P43681 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16657872 0.81 RAB9A (0.50) NPC1RAB9APKMSMN1; SMN2ALDH1A1
SCHEMBL20143351 0.71 NPC1 (0.46) NPC1RAB9APKMSMN1; SMN2ALDH1A1
SCHEMBL1147615 0.67 NPC1 (0.63) NPC1RAB9APKMSMN1; SMN2KDM4E
SCHEMBL11538755 0.66 NPC1 (0.72) NPC1RAB9APKMSMN1; SMN2ALDH1A1
SCHEMBL22839376 0.66 NPC1 (0.52) NPC1RAB9APKMSMN1; SMN2ALDH1A1
SCHEMBL17266541 0.65 NPC1 (0.66) NPC1RAB9APKMSMN1; SMN2ALDH1A1
SCHEMBL29655221 0.65 NPC1 (0.66) NPC1RAB9APKMSMN1; SMN2ALDH1A1
SCHEMBL18542571 0.65 LMNA (0.36) NPC1RAB9ASMN1; SMN2KDM4EHTT
SCHEMBL28711768 0.65 EGFR (0.55) NPC1RAB9APKMSMN1; SMN2ALDH1A1
SCHEMBL6255733 0.65 NPC1 (0.59) NPC1RAB9APKMSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170244047-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE DUK SAN NEOLUX CO., LTD. (KR) 2017-08-24 — — US disclosed
US-20170244047-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE DUK SAN NEOLUX CO., LTD. (KR) 2017-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170244047-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE NFE2L2, LAGE3, OR51E2 NPC1 826/4885RAB9A 2894/4885PKM 2395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback